Biktarvy, formally known as bictegravir, represents a powerful single-tablet therapy for controlling HIV infection. This medication unites three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the virus's ability to copy within the body, remarkably decreasing the viral burden. For many in